We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+13.63%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$48.3B
AUM Growth
+$4.2B
(+9.5%)
Cap. Flow
-$749M
Cap. Flow
% of AUM
-1.55%
Top 10 Holdings %
Top 10 Hldgs %
25.22%
Holding
973
New
114
Increased
273
Reduced
385
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$516M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$253M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$210M |
| 4 |
Broadcom
AVGO
|
+$161M |
| 5 |
Uber
UBER
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$340M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$328M |
| 3 |
VMW
VMware, Inc
VMW
|
+$255M |
| 4 |
Chevron
CVX
|
+$187M |
| 5 |
lululemon athletica
LULU
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.57% |
| 2 | Healthcare | 16.39% |
| 3 | Financials | 11.55% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FUSN
701
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $3.84M | 0.01% |
+400,000
| New | +$1.94M |
|
702
GitLab
GTLB
$6.03B
| $3.78M | 0.01% |
60,000
-40,000
| -40% | -$2.02M |
|
703
Darling Ingredients
DAR
$9.62B
| $3.74M | 0.01% |
75,000
| – | – |
|
704
VF Corp
VFC
$5.8B
| $3.69M | 0.01% |
196,100
+117,500
| +149% | +$2.02M |
|
705
Finance of America Companies
FOA
$197M
| $3.68M | 0.01% |
334,288
-1,555
| -0.5% | -$16K |
|
706
Sprinklr
CXM
$1.55B
| $3.61M | 0.01% |
+300,000
| New | +$4.12M |
|
707
Kimbell Royalty Partners
KRP
$1.43B
| $3.61M | 0.01% |
240,000
-60,000
| -20% | -$940K |
|
708
X4 Pharmaceuticals
XFOR
$393M
| $3.59M | 0.01% |
142,544
| – | – |
|
709
Fox Class B
FOX
$23.2B
| $3.54M | 0.01% |
128,165
-3,000
| -2% | -$84.2K |
|
|
GTM
710
ZoomInfo Technologies
GTM
$1.22B
| $3.51M | 0.01% |
+190,000
| New | +$2.98M |
|
711
Camden Property Trust
CPT
$11B
| $3.48M | 0.01% |
35,016
-26,184
| -43% | -$2.42M |
|
712
Mobileye
MBLY
$2.13B
| $3.47M | 0.01% |
+80,000
| New | +$3.15M |
|
713
Werner Enterprises
WERN
$2.21B
| $3.41M | 0.01% |
80,545
-90,000
| -53% | -$3.53M |
|
|
HARP
714
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $3.41M | 0.01% |
+300,000
| New | +$2.36M |
|
715
Lyft
LYFT
$6.19B
| $3.37M | 0.01% |
225,000
-25,000
| -10% | -$291K |
|
|
IGMS
716
DELISTED
IGM Biosciences
IGMS
| $3.32M | 0.01% |
+400,000
| New | +$2.32M |
|
|
BPMC
717
DELISTED
Blueprint Medicines
BPMC
| $3.32M | 0.01% |
+36,000
| New | +$2.33M |
|
718
Exelon
EXC
$46.7B
| $3.3M | 0.01% |
91,932
-897,600
| -91% | -$34.6M |
|
719
Harmony Biosciences
HRMY
$2.26B
| $3.23M | 0.01% |
100,000
-1,320,000
| -93% | -$36.8M |
|
|
HLVX
720
DELISTED
HilleVax
HLVX
| $3.18M | 0.01% |
198,439
+21,927
| +12% | +$291K |
|
721
International Paper
IP
$21.5B
| $3.18M | 0.01% |
88,087
-5,905
| -6% | -$206K |
|
|
AVDL
722
DELISTED
Avadel Pharmaceuticals
AVDL
| $3.18M | 0.01% |
225,000
-1,500,000
| -87% | -$17.6M |
|
|
BORR
723
Borr Drilling
BORR
$1.2B
| $2.94M | 0.01% |
+400,000
| New | +$2.63M |
|
724
News Corp Class B
NWS
$18.3B
| $2.87M | 0.01% |
111,534
-3,300
| -3% | -$74.7K |
|
725
Campbell Soup
CPB
$6.73B
| $2.86M | 0.01% |
66,046
-59,850
| -48% | -$2.46M |
|
Similar funds
Adage Capital Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Adage Capital Partners held 973 positions worth $48.3B, up 9.5% from $44.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners's Q4 2023 filing shows 114 new, 273 increased, 385 reduced and 131 closed positions. Its largest new stake was Uber: 2,148,900 shares worth $132M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $340M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q4 2023 buy was Uber: 2,148,900 shares worth $132M.
- Adage Capital Partners added most to Hess in Q4 2023, an estimated $516M increase.
- Adage Capital Partners's biggest Q4 2023 reduction was lululemon athletica, cutting an estimated $124M.
- Adage Capital Partners fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $340M.
- Adage Capital Partners's ten largest holdings make up 25% of its $48.3B portfolio in Q4 2023.
- Adage Capital Partners opened 114 new positions and closed 131 in Q4 2023.
- Adage Capital Partners's portfolio value rose 9.5% quarter-over-quarter to $48.3B.
Based on Adage Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.